Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (123)

2023

  1. CLINICAL VIEW ON SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS IN A MEDICALLY SUPERVISED INJECTING ROOM: A DECADE OF EXPERIENCE

    Actas espanolas de psiquiatria, Vol. 51, Núm. 4, pp. 188-191

  2. Clinical features and factors related to lifetime suicidal ideation and suicide attempts in patients who have had substance-induced psychosis across their lifetime

    Psychiatry Research, Vol. 323

2022

  1. A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

    Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976

  2. Confirmatory factor analysis of 20-item toronto alexithymia scale in spanish patients with substance use disorder

    Actas espanolas de psiquiatria, Vol. 50, Núm. 5, pp. 208-215

2021

  1. Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life

    Frontiers in Psychiatry, Vol. 12

  2. Is alexithymia related to retention and relapses in patients with substance use disorders?: A one year follow-up study

    Addictive Behaviors, Vol. 113

  3. Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders

    Journal of Attention Disorders, Vol. 25, Núm. 7, pp. 978-988

  4. Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: A systematic review

    European Review for Medical and Pharmacological Sciences, Vol. 25, Núm. 13, pp. 4554-4562

  5. Psychosis induced by abuse of ayahuasca: a case report

    Revista Colombiana de Psiquiatria, Vol. 50, Núm. 1, pp. 43-46

  6. Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit

    Addictive Behaviors, Vol. 117

  7. Validation of the Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales in French, Spanish, and German Languages, among a Sample of Opioid Users

    European Addiction Research, Vol. 27, Núm. 5, pp. 326-331

2020

  1. Benefits of EEG-Neurofeedback on the Modulation of Impulsivity in a Sample of Cocaine and Heroin Long-Term Abstinent Inmates: A Pilot Study

    International Journal of Offender Therapy and Comparative Criminology, Vol. 64, Núm. 12, pp. 1275-1298

  2. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review

    Reproductive Health, Vol. 17, Núm. 1

  3. Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease

    Quality of Life Research, Vol. 29, Núm. 3, pp. 607-617

  4. Corrigendum to “Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample” (Drug and Alcohol Dependence (2018) 187 (358–362), (S0376871618302096), (10.1016/j.drugalcdep.2018.03.013))

    Drug and Alcohol Dependence

  5. Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features

    Frontiers in Psychiatry, Vol. 11

2019

  1. ADGRL3 (LPHN3) variants predict substance use disorder

    Translational Psychiatry, Vol. 9, Núm. 1

  2. Cocaine-Induced Psychosis and Asenapine as Treatment: A Case Study

    Psychopharmacology bulletin, Vol. 49, Núm. 1, pp. 92-97

  3. Difficulties in initiating hepatitis C treatment in patients with opioid usdisorder: Patient's perspective

    Heroin Addiction and Related Clinical Problems, Vol. 21, Núm. 3, pp. 47-51

  4. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 9, pp. 579-592